Acute graft-versus-host disease prophylaxis after reduced-intensity conditioning in allogeneic peripheral blood stem cell transplantation from HLA-identical sibling donors. Comparison of CsA and MMFvs CsA and MTX

被引:0
|
作者
Pinana, J. L. [1 ]
Valcarcel, D. [1 ]
Fernandez-Aviles, F. [2 ]
Martino, R. [1 ]
Rovira, M. [2 ]
Barba, P. [1 ]
Sureda, A. [1 ]
Carreras, E. [2 ]
Sierra, J. [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S283 / S284
页数:2
相关论文
共 50 条
  • [31] Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation
    Visentainer, JEL
    Lieber, SR
    Persoli, LBL
    Vigorito, AC
    Aranha, FJP
    Eid, KAD
    Oliveira, GB
    Miranda, ECM
    de Souza, CA
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (11) : 1044 - 1050
  • [32] Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors
    P Martin
    N Bleyzac
    G Souillet
    C Galambrun
    Y Bertrand
    P H Maire
    R W Jelliffe
    G Aulagner
    Bone Marrow Transplantation, 2003, 32 : 777 - 784
  • [33] Cytokines dysregulation and chronic graft-versus-host disease after allogeneic haematopoietic stem cells transplantation with reduced-intensity conditioning
    Skert, C
    Damiani, D
    Michelutti, A
    Stocchi, R
    Calistri, E
    Patriarca, F
    Cerno, M
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S151 - S151
  • [34] Graft from HLA-identical sibling versus HLA-allelic-matched, unrelated donor (10/10) in patients undergoing allogeneic stem cell transplantation following reduced-intensity conditioning regimen
    de Berranger, E.
    Wemeau, M.
    Herbaux, C.
    Cracco, P.
    Jouet, J. -P.
    Yakoub-Agha, I.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S298 - S298
  • [35] Clinical Benefit of Low-Dose Antithymocyte Globulin-Thymoglobulin as Graft-versus-Host Disease Prophylaxis in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Identical Donors
    Takeuchi, Yuki
    Miyao, Kotaro
    Negishi, Shuto
    Ohara, Fumiya
    Motegi, Kenta
    Wakabayashi, Hiroya
    Yokota, Hirofumi
    Kuwano, Shihomi
    Sawa, Hitomi
    Inagaki, Yuichiro
    Sawa, Masashi
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (05): : 325e1 - 325e10
  • [36] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    de Lavallade, H
    Faucher, C
    Bilger, K
    Vey, N
    Stoppa, AM
    Gravis, G
    Coso, D
    Viens, P
    Gastaut, JA
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 527 - 530
  • [37] Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    H de Lavallade
    C Faucher
    K Bilger
    N Vey
    A-M Stoppa
    G Gravis
    D Coso
    P Viens
    J-A Gastaut
    D Blaise
    Bone Marrow Transplantation, 2004, 34 : 527 - 530
  • [38] Impact of graft composition on outcome following peripheral blood stem cell transplantation from HLA-identical sibling donors
    Clausen, J
    Wolf, D
    Petzer, AL
    Gunsilius, E
    Gastl, G
    Nachbaur, D
    BONE MARROW TRANSPLANTATION, 2006, 37 : S70 - S70
  • [39] Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
    M Mohty
    K Bilger
    E Jourdan
    M Kuentz
    M Michallet
    J H Bourhis
    N Milpied
    L Sutton
    J P Jouet
    M Attal
    P Bordigoni
    J Y Cahn
    A Sadoun
    N Ifrah
    D Guyotat
    C Faucher
    N Fegueux
    J Reiffers
    D Maraninchi
    D Blaise
    Leukemia, 2003, 17 : 869 - 875
  • [40] Higher doses of CD34+peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
    Mohty, M
    Bilger, K
    Jourdan, E
    Kuentz, M
    Michallet, M
    Bourhis, JH
    Milpied, N
    Sutton, L
    Jouet, JP
    Attal, M
    Bordigoni, P
    Cahn, JY
    Sadoun, A
    Ifrah, N
    Guyotat, D
    Faucher, C
    Fegueux, N
    Reiffers, J
    Maraninchi, D
    Blaise, D
    LEUKEMIA, 2003, 17 (05) : 869 - 875